Contact us

Support


Home > Knowledge hub & News > Pharmstandard and Roche to localize production in the Russian Federation

Pharmstandard and Roche to localize production in the Russian Federation


31 August 2017
RIA Novosti

The Russian Pharmstandard pharmaceutical company and Swiss Roche plans to localize the manufacture of Gaziva preparation for chronic lymphocytic leukemia and follicular lymphoma at the Pharmstandard-UfaVITA plant in the Republic of Bashkortostan. The relevant memorandum of intent was signed by the parties during a press conference.

The companies also intend to export drugs produced in Russia.

84.7 mln
Moscow

Investor profile

F. Hoffmann-La Roche Ltd

Switzerland

Company's website: http://www.roche.com

T: +41 61 688 1111

A public company

Contact: Severin Schwan, General Director

Roche Holding is a holding company for Roche, a group of pharmaceutical companies. The group is based on F. Hoffmann-La Roche, a Swiss pharmaceutical company, one of the world’s leading companies in the field of pharmaceuticals and diagnostics.

Subscribe to Newsletters

Email:
 

Send by email

Email:
 

Comment

Email:
Name:
Comment:
Code:
Enter code